title: Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice.
abstract: Disseminated aspergillosis is responsible for a high mortality rate, despite the use of antifungal drugs. Adjuvant therapies are urgently needed to improve the outcome. The aim of this study was to demonstrate that the cytoprotective effect of erythropoietin (EPO) combined with amphotericin B can reduce the mortality rate in a murine model of disseminated aspergillosis. After infection with Aspergillus fumigatus, neutropenic mice were randomized to receive vehicle or 7.5 mg/kg liposomal amphotericin B (LAmB) or 7.5 mg/kg LAmB combined with 1000 IU/kg EPO (16 mice per group). Aspergillus galactomannan and organ cultures were performed to evaluate fungal burden at day 5. Cumulative long-term survival was analyzed at day 12 post-infection according to the Kaplan-Meier method. At day 5, fungal burden was similar between non-treated and treated groups. At day 12, mortality rates were 75, 62.5, and 31% in control group, LAmB group, and EPO/LAmB group, respectively. We observed a significant decrease in mortality using EPO/LAmB combination compared to control group (p < 0.01). LAmB single treatment did not improve the survival rate compared to control group (p = 0.155). Our results provide the first evidence that EPO improved the outcome of mice presenting with disseminated aspergillosis when combined with amphotericin B.
authors.affiliation: Institut de Parasitologie et Mycologie Médicale, Hospices Civils de Lyon , Lyon , France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Rousseau
authors.affiliation: Institut de Parasitologie et Mycologie Médicale, Hospices Civils de Lyon , Lyon , France ; Malaria Research Unit, ICBMS, CNRS UMR 5246, University Lyon 1 , Lyon , France.
authors.forename: Stephane
authors.initials: S
authors.lastname: Picot
authors.affiliation: Institut de Parasitologie et Mycologie Médicale, Hospices Civils de Lyon , Lyon , France ; Malaria Research Unit, ICBMS, CNRS UMR 5246, University Lyon 1 , Lyon , France.
authors.forename: Anne-Lise
authors.initials: AL
authors.lastname: Bienvenu
keywords: adjuvant therapy; amphotericin B; erythropoietin; invasive aspergillosis; mortality; murine model